Acadia Healthcare Co. (NASDAQ:ACHC) Director Reeve B. Waud sold 84,208 shares of the firm’s stock in a transaction that occurred on Tuesday, September 13th. The stock was sold at an average price of $51.71, for a total transaction of $4,354,395.68. Following the sale, the director now owns 55,673 shares of the company’s stock, valued at $2,878,850.83. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Acadia Healthcare Co. (NASDAQ:ACHC) opened at 51.03 on Tuesday. Acadia Healthcare Co. has a 12 month low of $48.05 and a 12 month high of $75.50. The company has a market cap of $4.46 billion, a price-to-earnings ratio of 27.26 and a beta of 0.84. The company’s 50-day moving average is $51.73 and its 200-day moving average is $55.57.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. Acadia Healthcare had a return on equity of 9.35% and a net margin of 6.44%. The business earned $756.50 million during the quarter, compared to analysts’ expectations of $752.57 million. During the same period in the prior year, the business earned $0.57 EPS. Acadia Healthcare’s revenue for the quarter was up 66.8% compared to the same quarter last year. On average, equities research analysts anticipate that Acadia Healthcare Co. will post $2.64 earnings per share for the current year.

A number of analysts have issued reports on the stock. Royal Bank Of Canada reduced their target price on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Leerink Swann reiterated a “buy” rating and issued a $80.00 target price on shares of Acadia Healthcare in a research note on Sunday, August 28th. Jefferies Group reiterated a “buy” rating and issued a $85.00 target price on shares of Acadia Healthcare in a research note on Monday, June 27th. RBC Capital Markets reiterated an “outperform” rating and issued a $78.00 target price (down from $86.00) on shares of Acadia Healthcare in a research note on Monday, August 1st. Finally, Robert W. Baird reduced their target price on shares of Acadia Healthcare from $67.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, September 15th. One equities research analyst has rated the stock with a sell rating and twelve have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $78.46.

Several institutional investors have recently modified their holdings of ACHC. Calvert Investment Management Inc. boosted its position in shares of Acadia Healthcare by 0.9% in the second quarter. Calvert Investment Management Inc. now owns 4,192 shares of the company’s stock valued at $232,000 after buying an additional 39 shares in the last quarter. Navellier & Associates Inc boosted its position in shares of Acadia Healthcare by 0.5% in the second quarter. Navellier & Associates Inc now owns 8,208 shares of the company’s stock valued at $455,000 after buying an additional 42 shares in the last quarter. OLD National Bancorp IN boosted its position in shares of Acadia Healthcare by 3.3% in the second quarter. OLD National Bancorp IN now owns 4,901 shares of the company’s stock valued at $272,000 after buying an additional 155 shares in the last quarter. Suntrust Banks Inc. boosted its position in shares of Acadia Healthcare by 5.1% in the second quarter. Suntrust Banks Inc. now owns 4,827 shares of the company’s stock valued at $266,000 after buying an additional 236 shares in the last quarter. Finally, Legal & General Group Plc boosted its position in shares of Acadia Healthcare by 6.0% in the second quarter. Legal & General Group Plc now owns 5,366 shares of the company’s stock valued at $297,000 after buying an additional 302 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.

5 Day Chart for NASDAQ:ACHC

Receive News & Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.